PMID- 12732396 OWN - NLM STAT- MEDLINE DCOM- 20031211 LR - 20190718 IS - 0021-9150 (Print) IS - 0021-9150 (Linking) VI - 168 IP - 1 DP - 2003 May TI - A novel functional polymorphism in the PECAM-1 gene (53G>A) is associated with progression of atherosclerosis in the LOCAT and REGRESS studies. PG - 131-8 AB - A 53G>A polymorphism identified in the 5' untranslated region (5'UTR) of the platelet endothelial cell adhesion molecule-1 (PECAM-1) gene alters a putative shear stress responsive element (SSRE). PECAM-1 was shown to be responsive to shear stress and transient transfection of human umbilical vein endothelial cell (HUVECs) with two luciferase reporter constructs driven by the PECAM-1 promoter and 5'UTR showed a response of the 53G allele, not the 53A allele, to shear stress. Association between the 53G>A, and the previously published L125V polymorphism, and coronary atherosclerosis was examined in two angiographic studies. The frequencies of the rare alleles of the 53G>A and L125V polymorphisms were 0.01 and 0.49, respectively, in the Lopid Coronary Angiography Trial (LOCAT) study and 0.02 and 0.49, respectively, in the Regression Growth Evaluation Statin Study (REGRESS) study. Compared with 53G homozygotes, carriers of the 53A allele showed less focal progression of disease in the LOCAT study and a similar trend in the diffuse progression of disease in the REGRESS study, whereas no association between L125V and coronary atherosclerosis was observed in either study. These data demonstrate that the PECAM-1 gene is responsive to shear stress in vitro and that decreased PECAM-1 gene expression in 53A carriers may influence reduced progression of vessel stenosis in patients with coronary artery disease. FAU - Elrayess, Mohamed A AU - Elrayess MA AD - The Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, Royal Free and University College Medical School, University College London, Rayne Building, 5 University Street, UK. m.rayess@ucl.ac.uk FAU - Webb, Karen E AU - Webb KE FAU - Flavell, David M AU - Flavell DM FAU - Syvanne, Mikko AU - Syvanne M FAU - Taskinen, Marja-Riitta AU - Taskinen MR FAU - Frick, M Heikki AU - Frick MH FAU - Nieminen, Markku S AU - Nieminen MS FAU - Kesaniemi, Y Antero AU - Kesaniemi YA FAU - Pasternack, Amos AU - Pasternack A FAU - Jukema, J Wouter AU - Jukema JW FAU - Kastelein, John J P AU - Kastelein JJ FAU - Zwinderman, Aeilko H AU - Zwinderman AH FAU - Humphries, Steve E AU - Humphries SE LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Ireland TA - Atherosclerosis JT - Atherosclerosis JID - 0242543 RN - 0 (DNA, Complementary) RN - 0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors) RN - 0 (Platelet Endothelial Cell Adhesion Molecule-1) RN - 126547-89-5 (Intercellular Adhesion Molecule-1) RN - EC 1.2.1.- (Glyceraldehyde-3-Phosphate Dehydrogenases) SB - IM MH - Aged MH - Alleles MH - Computer Systems MH - Coronary Angiography MH - Coronary Artery Disease/drug therapy/*genetics MH - DNA, Complementary/genetics MH - Disease Progression MH - Endothelium, Vascular/chemistry/cytology MH - Finland MH - Follow-Up Studies MH - Gene Frequency/genetics MH - Gene Order/*genetics MH - Genetic Predisposition to Disease/genetics MH - Genotype MH - Glyceraldehyde-3-Phosphate Dehydrogenases/genetics MH - Humans MH - Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use MH - Intercellular Adhesion Molecule-1/genetics MH - Male MH - Middle Aged MH - Multivariate Analysis MH - Platelet Endothelial Cell Adhesion Molecule-1/*genetics MH - Polymerase Chain Reaction MH - Polymorphism, Genetic/*genetics MH - Promoter Regions, Genetic/genetics MH - Statistics as Topic MH - Stress, Mechanical MH - Transfection MH - Umbilical Veins/chemistry/cytology EDAT- 2003/05/07 05:00 MHDA- 2003/12/12 05:00 CRDT- 2003/05/07 05:00 PHST- 2003/05/07 05:00 [pubmed] PHST- 2003/12/12 05:00 [medline] PHST- 2003/05/07 05:00 [entrez] AID - S0021-9150(03)00089-3 [pii] AID - 10.1016/s0021-9150(03)00089-3 [doi] PST - ppublish SO - Atherosclerosis. 2003 May;168(1):131-8. doi: 10.1016/s0021-9150(03)00089-3.